Bambusa Therapeutics
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.
bambusatx.comCompany Details
Founded
- 2024
Employees
- Between 2 - 10 employees
Raised
- $105,000,000
Public
- No
Acquired
- No
CEO
Shanshan Xu
Founders
- Helmut JeggleShanshan Xu
Company Collections
These are collections Bambusa Therapeutics is a part of. Click on the collection name to view similar companies.